Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

EGM Statement

30 Aug 2005 11:08

Stanelco PLC30 August 2005 30 August 2005 Stanelco PLC ("Stanelco" or "the Company") EGM Statement Stanelco PLC is pleased to announce that all the resolutions at the Company'sEGM held at 10.00a.m. this morning were duly passed. The acquisition of BiotecHoldings GmbH ("Biotec") will therefore be completed shortly. As a result, the previously announced conditional sale of a 50% interest inBiotec to SP Metal S.A. ("SP Metal") will also shortly become effective and theconsideration received by Stanelco will be used to fund 50% of the Biotecacquisition. Under the joint venture more of Biotec's considerable IntellectualProperty portfolio will be commercialised. Biotec have received a conditionalcommitment from SP Metal for an annual purchase of approximately 10,000 metrictonnes of Biotec's biodegradable plastic pellet worth in excess of €20m peryear. Stanelco and SP Metal had initially agreed to increase Biotec's productioncapacity of biodegradable pellets to at least 12,000 metric tonnes within ninemonths via a joint investment programme of up to €4.5m. However due to furtherrecent improvements in both the production procedures and the ability to processthe materials, a capacity of 24,000 tonnes for an investment of €2m is nowenvisaged within the same period. In an earlier announcement today, NatureWorks LLC, a wholly owned subsidiary ofCargill Inc has agreed the supply of the major component of Biotec's Starpolmaterials which will make Biotec's products price competitive with a number ofmaterials currently used in the target market segments. Business update GREENSEALTM Commercial trials with ASDA Stores Limited ("ASDA") suppliers have beensuccessfully completed and the 12 month exclusivity period with ASDA, who havecommitted to converting several hundred machines in the period, commenced on28th July 2005. To date, two contracts orders have been received from dedicatedASDA suppliers covering 5 machines in total. Martin Wagner, recently recruited from Asda, as Commercial Director of StanelcoRF Technologies Limited, is now leading the drive for roll out and furthercommercialisation in the UK. In addition the Company has reached commercial agreement with G Mondini Spa, aworld leading manufacturer of tray lidding machines, to jointly develop apurpose built radio frequency ("RF") tray lidding machine using Stanelco'sGREENSEALTM technology. This is an important development as it should allowStanelco to supply its technology to food packers as part of new originalequipment manufacter ("OEM") machines as an alternative to retrofitting existingmachines in operation. This will greatly speed up the acceptance of theGREENSEALTM technology as an industry standard within the packaging industry. We remain confident of being able to announce a number of additionaldevelopments in relation to the commercialisation of this technology in thecoming months. Frogpack The commercialisation of Frogpack, our simple, new, patented, lightweight,highly impact resistant, low cost and greener packaging format is developingwell with orders received from existing distributors and agreements beingnegotiated with further distributors in North America. Philip Lovegrove, Chairman of Stanelco said: "I am pleased with the continued progress at the company. We have a strongmanagement team with some extremely exciting opportunities ahead of us. Thepassing of all resolutions at today's EGM, allowing us to complete the Biotecacquisition will enable further progress towards our aim of becoming one of theworld's leading exponents of viable, alternative, environmentally responsiblepackaging methods." Ends For further information please contact:Ian Balchin, Chief ExecutiveStanelco PLCTel: +44 (0)2380 867 100 Jonathon Brill/Billy CleggFinancial DynamicsTel: +44 (0)20 7831 3113 About Stanelco plc The Stanelco Group of companies (the Group) has brought together expertise inradio frequency (RF) technology, RF applications and biodegradable materialsciences to create a revolutionary range of packaging technologies. Stanelco's philosophy is that new products and processes must offer solutionsand applications which: • give higher added value, • are greener, more environmentally sustainable than those they replace • and have protectable intellectual property rights. Stanelco will develop the products and processes to a demonstration stage andthen work with partners in order to reach the markets; and under thesecircumstances Stanelco will usually seek to license its technology. Stanelcoinvests considerable time and resources in ensuring its technologies areprotected via layers of patents wherever possible. In this way Stanelco believes it can minimise commercial risk and preserve thehighest value for shareholders. The products offering the prospect of near term revenue generation are beinggiven priority over the Group's resources. Stanelco was founded in 1953 and is a world leader in the development of radiofrequency technologies for processing polymers for edible and packagingapplications and the design and manufacture of optical fibre technology,induction heating and dielectric welding equipment. Stanelco's Currentdevelopments include GREENSEAL Food tray lidding technology, STARPOL (starch /pva blended material), FrogPack high impact low cost packaging format,CradleWrap range of biodegradable air cushion packaging, Soluble tape, 100%water-soluble films and adhesives, Biodegradable Airbag (void fill) packaging,water-soluble detergent capsules, edible sachets and waste packing. GREENSEAL, STARPOL, Frog Pack and CradleWrap are all trademarks of the Stanelcoplc group. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Apr 20071:34 pmRNSResult of AGM
27th Apr 20071:32 pmRNSDirectorate Change
26th Apr 20071:42 pmRNSAnnual Information Update
13th Apr 200712:29 pmRNSDirector's Dealing
30th Mar 20071:32 pmRNSAnnual Report and Accounts
23rd Mar 20075:09 pmRNSNotifiable Interest
21st Mar 20077:03 amRNSPreliminary Results
14th Mar 20075:59 pmRNSHolding(s) in Company
26th Feb 20077:01 amRNSBoard Appointment
23rd Feb 20073:18 pmRNSHolding(s) in Company
30th Jan 20079:00 amRNSNotice of Results
18th Dec 20064:58 pmRNSTotal Voting Rights
8th Dec 200612:31 pmRNSNotifiable Interest
28th Nov 20063:32 pmRNSNotifiable Interest
17th Nov 20063:33 pmRNSNotifiable Interest
16th Nov 20069:02 amRNSNotifiable Interest
14th Nov 20064:37 pmRNSDirectorate Change
14th Nov 20064:09 pmRNSDirector/PDMR Shareholding
14th Nov 20064:03 pmRNSNotifiable Interest
14th Nov 20069:55 amRNSNotifiable Interest
10th Nov 200610:29 amRNSHolding(s) in Company
9th Nov 200611:45 amRNSNotifiable Interest
8th Nov 20063:08 pmRNSNotifiable Interest
7th Nov 20068:01 amRNSIssue of Equity
6th Nov 200612:12 pmRNSResult of EGM
3rd Nov 20064:41 pmRNSNotifiable Interest
3rd Nov 20061:17 pmRNSOpen Offer Result - Amendment
2nd Nov 20066:03 pmRNSOpen Offer Result
31st Oct 200611:54 amRNSNotifiable Interest
17th Oct 20065:54 pmRNSNotifiable Interest
17th Oct 200610:44 amRNSNotifiable Interest
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.